FROM A-LEVELS OR AN OVERSEAS DEGREE TO PRACTISING IN THE UKSearch the guide
← All news
NEW MEDICINES AND DRUG DISCOVERY · MHRA (UK MEDICINES REGULATOR) · 20 October 2026

IXCHIQ Chikungunya vaccine: UK marketing authorisation withdrawn following safety review

Synopsis

IXCHIQ Chikungunya vaccine: UK marketing authorisation withdrawn following safety review - the UK marketing authorisation for the IXCHIQ vaccine (chikungunya vaccine) has been withdrawn and the product is being removed from the UK market

Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.

Read the full story at MHRA (UK medicines regulator) ↗

More in New medicines and drug discovery